Switch from calcineurin inhibitors to belatacept in kidney transplant patients with chronic-active antibody mediated rejection results in lower decline in kidney function at three years - Normandie Université Access content directly
Journal Articles Journal of Nephrology Year : 2021

Switch from calcineurin inhibitors to belatacept in kidney transplant patients with chronic-active antibody mediated rejection results in lower decline in kidney function at three years

Tristan de Nattes
Sophie Candon
  • Function : Author
Isabelle Etienne
  • Function : Author
Charlotte Laurent
  • Function : Author
Marie Matignon
  • Function : Author
Antoine Morel
  • Function : Author
Johan Noble
  • Function : Author
  • PersonId : 1262082
  • IdHAL : noble-johan
Martin Planchais
  • Function : Author
Dominique Guerrot
  • Function : Author
Dominique Bertrand
  • Function : Author
No file

Dates and versions

hal-03751917 , version 1 (16-08-2022)

Identifiers

Cite

Tristan de Nattes, Arnaud François, Sophie Candon, Isabelle Etienne, Charlotte Laurent, et al.. Switch from calcineurin inhibitors to belatacept in kidney transplant patients with chronic-active antibody mediated rejection results in lower decline in kidney function at three years. Journal of Nephrology, 2021, 34 (6), pp.2159-2162. ⟨10.1007/s40620-021-01099-7⟩. ⟨hal-03751917⟩
22 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More